κ-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes

Biochemical Pharmacology

Volumn 61, Issue 9, 2001, Pages 1145-1151

  Peterson, Phillip K ^a,b   Gekker, Genya ^a,b   Lokensgard, James R ^a,b   Bidlack, Jean M ^c   Chang, An Chih ^d   Fang, Xingin ^d   Portoghese, Philip S ^d  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

opioid receptor ligands; AIDS; CD4+ lymphocytes; HIV; Opioids; U50,488

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; KAPPA OPIATE RECEPTOR AGONIST;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HIV-1; HUMANS; RECEPTORS, OPIOID, KAPPA;

EID: 0035342409     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00574-3     Document Type: Article

References (29)

1. The AIDS epidemic: Considerations for the 21st century
2. Survival after introduction of HAART in people with known duration of HIV-1 infection
3. Evidence for opioid receptors on cells involved in host defense and the immune system
4. Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations
5. κ opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression
6. U50,488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages
7. Aspartic acid conjugates of 2-(3,4-dicholorophenyl)-N-methyl-N-[(1S)-1-(3-aminophenyl)-2- (1-pyrrolidinyl)ethyl]acetamide: κ opioid receptor agonists with limited access to the central nervous system
8. TENA, a selective kappa opioid receptor antagonist
9. Differential κ-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation
10. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures
11. G-protein-coupled receptor heterodimerization modulates receptor function
12. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type I
13. International Union of Pharmacology. XII. Classification of opioid receptors
14. Opiates transdeactivate chemokine receptors: δ and μ opiate receptor-mediated heterologous desensitization
15. Opioid receptors on cells of the immune system: Evidence for δ- and κ-classes
16. Sequence of κ-opioid receptor cDNA in the R1.1 thymoma cell line
17. Characterization of κ-opioid receptor transcripts expressed by T cells and macrophages
18. Identification of κ opioid receptors in the immune system by indirect immunofluorescence
19. Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry
20. Expression of kappa opioid receptors in human and monkey lymphocytes
21. Inhibition of T cell superantigen responses following treatment with the κ-opioid agonist U50,488H
22. κ-opioid regulation of thymocyte IL-7 receptor and C-C chemokine receptor 2 expression
23. Opiate receptor-mediated chemotaxis of human monocytes
24. Dynorphin and related opioid peptides enhance tumoricidal activity mediated by murine peritoneal macrophages
25. Inhibition of primary murine macrophage cytokine production in vitro following treatment with the κ-opioid agonist U50,488H
26. Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U50,488H
27. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages
28. κ-opioid potentiation of tumor necrosis factor-α-induced anti-HIV-1 activity in acutely infected human brain cell cultures
29. Opioids, opioid receptors and the immune system